Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "DNA Microarray (Genome Chip)" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about DNA Microarray (Genome Chip) for you to read. Along with our medical data and news we also list DNA Microarray (Genome Chip) Clinical Trials, which are updated daily. BioPortfolio also has a large database of DNA Microarray (Genome Chip) Companies for you to search.
Regulatory News: Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced that Stephan A. Grupp, MD, Ph.D., a leading pediatric oncologist at
The popular genome-editing system CRISPR–Cas9 is a powerful tool for altering DNA sequences. But experiments show that this system cannot edit target sites in DNA wrapped tightly around a protein, which might limit CRISPR’s usefulness #ResearchHighlig
The popular genome-editing system CRISPR–Cas9 is a powerful tool for altering DNA sequences. But experiments show that this system cannot edit target sites in DNA wrapped tightly around a protein, which might limit CRISPR’s usefulness #ResearchHighlight https://go.nature.com/2NThRcT
In January 2016, Independence Blue Cross and NantHealth announced the nation’s first coverage for a whole genome sequencing and proteome
A team of researchers from Israel and the United States has released the improved and accurate assembly of the intermediate wheatgrass genome. The latest version of the assembly has reached a scaffold N50 of 25.9 MB with 2.55% unfilled sequence gaps and complete BUSCO gene coverage of 97.9%. Dr. Lee DeHaan of The Land Institute is leading efforts t...
Potato's tetraploid genome requires a more powerful genome editing system. Scientist Hiroaki Kusano of Tokyo University of Science and colleagues apply the translational enhancer dMac3 to the Cas9 expression vector to increase the amount of Cas9 proteins produced inside potato cells. dMac3 is a 161-bp region of the OsMac3 mRNA, which promotes effic...
New license agreements for CRISPR technology from Broad Institute and ERS Genomics extend industry-leading genome editing capabilities CARLSBAD, Calif., Sept. 18, 2018 /PRNewswire/ — Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the […] The post Thermo Fisher Scientific Expands Genome Editing IP Portfolio appeared first on Sy...
Amazfit Verge, Amazfit Health Band 1S and An Embedded AI Chipset Debut After Company’s Exceptional Second Quarter Growth Huami (NYSE: HMI), the second largest wearables company globally1, announced today the release of two new smart wearables and a new custom-designed chipset: The Amazfit Verge smartwatch, the redesigned Amazfit Health Band 1S...
BEIJING, Sept. 18, 2018 /PRNewswire/ -- Huami Corporation ("Huami" or the "Company") (NYSE: HMI), a biometric and activity data-driven company with significant expertise in smart wearable technology, today announced the launch of the new generation health band, Amazfit Health Band 1S, which delivers new features and benefits powered by AI technologies and brings advanced h...
NewsThey show pattern is misfolded in Fragile X Syndrome, a member of the class of disorders that also includes ALS and Huntington's Disease.Contributed Author:
NewsNew chip-sized device could help manufacturers measure laser power in real time.Contributed Author: National Institut
NewsResearchers reported the first use of CRISPR genome-wide screening to identify a gene that helps cells resist flavivirus infection.
NewsResearchers report the first use of CRISPR genome-wide screening to identify a gene that helps cells resist flavivirus infection.
Artificial intelligence has a way of inspiring wonder and uneasiness at the same time, particularly when it shows that it can outperform humans while hiding exactly how it goes about its business. The latest group of humans to be mysteriously surpassed by artificial intelligence, or AI, consists of pathologists—specifically, pathologists tasked with inspecting whole-slide images of lung tissue a...
Montecito Medical Real Estate, a premier owner of medical office buildings throughout the U.S., has acquired the University Medicine Medical Office Building in East Providence, Rhode Island. University Medicine, which is part of
CAMBRIDGE, UK, 18 September 2018 – EVONETIX LTD (‘Evonetix’), the company pioneering an innovative approach to scalable and high-fidelity gene synthesis, announced today that it has expanded its team three-fold, following a successful series A round of £9 million ($12.3M) to support the development of the Company’s technology. The appointments include physicis...
Pixium Vision announces the presentation of the first clinical results with PRIMA, its wireless implant, in patients with atrophic Dry-AMD EURETINA Annual Conference Vienna, Austria 20 - 23 September 2018 Paris, France. September 18, 2018 - 7.00 AM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable pat...
The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB is coordinating the establishment of a European research network to promote organ-on-a-chip technology. Organ-on-a-chip systems enable the recapitulation of human organ tissues on a very small scale. They are regarded as a...
(eLife ) Scientists have discovered a new family of molecules that work together to precisely remove unwanted DNA during reproduction in single-celled, freshwater organisms called ciliates.
(University of Pennsylvania) Researchers at the University of Pennsylvania have found a new common thread linking nearly all of the trinucleotide repeat expansion diseases, which include ALS, Huntington's Disease and Fragile X Syndrome, involving the complicated 3D patterns that the DNA is folded into in order to fit in the nucleus of the cell. Nearly all of the short tandem repeats known to grow ...
From AIoT, Blockchain, Gene Editing, Cell Therapy, to Immune-Oncology, Med x Tech Summit Asia (MEDTEX) brings over 30 cross-industry global key opinion leaders to Taipei. Taiwan, with high quality medical service and world’s top IT industry, has becoming one of the leaders in global healthcare technology and provider. On November 29 - 30, MEDTEX will...
Partnership will accelerate Congenica’s commercial expansion in the Chinese market Digital China Health is a key player in China’s national big-data strategy, with a strategic mission to advance health information technology Locally-adapted version of the Sapientia™ platform will enable genomic me...
Today, our Head of Genome Analytics Slavé Petrovski is participating in a panel at the Data For Good Exchange #d4gx to discuss the pre-competitive collaboration we have with Regeneron and the UK Biobank to accelerate medical discoveries. Read more - htt
Today, our Head of Genome Analytics Slavé Petrovski is participating in a panel at the Data For Good Exchange #d4gx to discuss the pre-competitive collaboration we have with Regeneron and the UK Biobank to accelerate medical discoveries. Read more - https://bloom.bg/2N8R4Ju pic.twitter.com/w4u8GCd5rT
SummaryIllumina Inc Illumina provides genomic sequencing and arraybased solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company's portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human wholegenome ...
Today, our Head of Genome Analytics Slavé Petrowski is participating in a panel at the Data For Good Exchange #d4gx to discuss the pre-competitive collaboration we have with Regeneron and the UK Biobank to accelerate medical discoveries. Read more - htt
Today, our Head of Genome Analytics Slavé Petrowski is participating in a panel at the Data For Good Exchange #d4gx to discuss the pre-competitive collaboration we have with Regeneron and the UK Biobank to accelerate medical discoveries. Read more - https://bloom.bg/2N8R4Ju pic.twitter.com/FzA33dErNI
Creative biotech startups are brewing inside a shipping container park that offers affordable research space for biologists, engineers and designers working together. The space will be opening its doors to the public this week for the London Design Festival. Chip ... The post Meet the Entrepreneurs Doing Biotech from Shipping Containers in London appeared first on Labiotech.eu.